Healthcare
Valio’s consumer-packaged infant formulas have received an export permit from the Chinese authorities.
As a valued member of our BioSpace community, we are eager to hear more from you and other readers in 2019. Let us know which topics you want to hear more about.
Collaboration will initially support nine new phase I/II clinical trials with Nanobiotix’s first-in-class agent NBTXR3 for use in treating six cancer types
MD Anderson Cancer Center and 4D pharma collaborate to evaluate live biotherapeutics in solid tumors
The University of Texas MD Anderson Cancer Center and 4D pharma today announced a strategic collaboration to evaluate 4D’s live biotherapeutic oncology pipeline across a range of cancer settings.
IDE application submitted to the FDA for HEMOSNOWTM
In a special report published by Reuters last month, Michele Gershberg describes the painstaking medical journey of her 4-year-old son. “It was March 2017. Over the previous year, the signs had mounted that something was wrong.”
Opposes IPI as Proposed Because of Serious Concerns About Patient Impact and Legality but Working on Alternatives; Releases Research Analysis on Myth of Physician Incentives in Part B System
FUJIFILM Corporation (President: Kenji Sukeno) announced today that Fujifilm is working towards improving the development of nucleic acid therapeutics by using liposomal drug delivery systems.
Follow-up investigations by the Wall Street Journal suggest that He Jiankui’s story may be just the tip of the iceberg of sloppy and unmonitored clinical trials using CRISPR in China.
In an endeavour to support development of Fertility and Reproductive Medicine in Oman, IVI Middle East Fertility Clinic Muscat– has organised a series of programmes for the medical community, in association with the Oman Society of Obstetrics and Gynecology
PRESS RELEASES